Numerous reasons, including an increase in chronic illnesses and disorders, rapid expansions in the biotechnology and pharmaceutical sectors, and increased research in regenerative treatments, are projected to boost the cell harvesting industry. Furthermore, the cost-effectiveness, convenience of use, and durability of harvesters, as well as technical breakthroughs and design improvement of cell harvester devices, drive the cell harvesting market's growth. Several corporations are also launching new products to boost their market position.
In December 2023, Cheetah Prime- A PerkinElmer Inc. project- will be demonstrated, shaped as an automated closed system letting out a chance of the sterile separation of different types of cells. Fat cell grabber machine is an advanced technology that aims at increasing the number and viability of cells.
In November 2023 indicated that Argos Technologies Inc. had entered into an agreement with a leading European research institute to carry out clinical trials on their sophisticated fat cell grabber machine (fat cell harvester), which could increase both numbers and viability of obtained cells.
In October 2023, Terumo Corporation bought Athersys, Inc., a firm involved in developing cellular therapy techniques, so as to get access to Athersys adipose-derived stem cell platform that might be integrated into Terumo’s cell harvesting devices.
CliniMACS Prodigy platform was launched by Miltenyi Biotec in the month of October 2023 as it sported an automated workflow for isolating and enriching cells from various sources making it ideal for R&D-related cellular therapies.
For instance, Orgenesis invested $50 million into Morgenesis after receiving FDA approval for its point-of-care autologous cell therapy product.
As an illustration, researchers at the University of Technology Sydney (UTS) came up with this idea along with Regeneus biotech company in June 2022, printed on a 3D printer microfluidic stem-cell harvesting system. In fact, it is a simple and cheap device that can trap stem cells escaping from bioreactor systems, facilitating cost-effective and scalable process control.
In March 2022 Stem Cell Therapies (SCT) Mission allocated $150 million to novel therapies that are safe, effective and accessible, thereby enhancing better health outcomes involving the patients as well as carers—Australian Government Department of Health and Aged Care said. Thereby, this mission funds projects to develop new therapies that are safe and effective for patients, to develop the workforce capacity, as well as translate stem cell innovations into commercial products.
However, the technical complexity of harvesters, coupled with ethical issues related to embryonic stem cell research may curb the growth of the cell harvesting market. Stringent government regulations and mandatory licensing rules may also hamper the market growth during the assessment period.
The cell harvesting market has been segmented into product type, application, and end user.
The cell harvesting market, on the basis of product type, has been segmented into manual cell harvesters and automated cell harvesters.
The manual cell harvesters segment is estimated to hold the largest share owing to the high preferability of manual cell harvesters, whereas the automated cell harvesters segment is expected to be the fastest growing segment due to increased awareness and rise in the use of automated technologies in devices.
The cell harvesting market, by application, has been segmented into biopharmaceutical application, stem cell research, and others.
The cell harvesting market, by end user, has been segmented into pharmaceutical companies, biotechnology companies, research institutes, and others.
The cell harvesting market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the cell harvesting market owing to a well-developed healthcare sector and growing healthcare expenditure. For instance, according to the data published by the Committee for a Responsible Federal Budget in May 2018, the US spent about USD 3.5 trillion, or 18% of its Gross Domestic Product (GDP) on health expenditures, which accounted for more than twice the average among developed countries in 2017. Additionally, many companies in this region focus on the innovation of new treatment options, thus being a lucrative option for the growth of the cell harvesting market in this region.
Europe is expected to hold the second largest position in the cell harvesting market. The market growth in this region owes to the availability of funds for research. For instance, according to the data published by the National Institute of Health Funding (NIHR) in 2016, funding of EUR 928 million was announced for new NIHR Biomedical Research Centers (BRC) and NIHR Clinical Research Facilities (CRF) for five years starting from April 2017.
Asia-Pacific is anticipated to be the fastest growing region in the cell harvesting market due to the presence of a huge patient population and continuously developing economies.
On the other hand, the Middle East and Africa has the least share of the market. The majority of the market of this region is expected to be held by the Middle Eastern region due to growing government initiatives for the healthcare sector.
Cell Harvesting Market Key players
The report for Cell Harvesting Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Recent Development
ADS-TEC is a producer and provider of high-quality, long-lasting Industrial IT systems, as well as high-performance battery systems and full storage solutions. ADS-in-house TEC's development is characterized by over 35 years of experience and professional skill in system development. ADS-TEC, a medium-sized company, employs around 240 people at two locations in Germany. The headquarters were transferred from Leinfelden-Echterdingen to a new facility in Nuertingen, near Stuttgart, in May 2014. The headquarters are supplemented by a manufacturing facility in Wilsdruff, near Dresden.
Argos Technologies delivers one-of-a-kind equipment and materials to help life scientists improve science. We stock the whole Argos Technologies product range, including the famous PolarSafe® products, for liquid handling, microbiology, cell biology, general laboratory, tabletop equipment, and cryogenic storage. Cryogenic storage racks and boxes, cryogenic vials and caps, upright freezer racks, labels, pipettes, pipette controllers, cell spreaders, mini centrifuges, centrifuge tubes, tube rotators, and other items are available in Agro technologies.
Intended Audience
| Report Attribute/Metric | Details |
| Â Â Market Size (2032) | Â 10.34 Billion |
| Â Â CAGR | Â 12.9% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â 2024-2032 |
| Â Â Historical Data | Â Â 2020 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Product Type, Application, and End user |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Ads-tec GmbH, Argos Technologies, Inc., Arthrex, Inc., Avita Medical, Bertin, connectorate, Cox Scientific, hynoDent AG, PerkinElmer Inc., Scinomix, Teleflex Incorporated, and TERUMO CORPORATION |
|   Key Market Opportunities | · Increase in chronic infections and diseases · The rapid growth of the biotechnology and pharmaceutical industries · Rising research in regenerative medicines |
|   Key Market Drivers | · Cost-effectiveness · Ease of use · The durability of harvesters · Technological advancements · Design development of cell harvester devices |
Cell Harvesting Market Highlights:
Frequently Asked Questions (FAQ) :
Cell harvesting is performed by separating the cell culture from the growing medium, involving techniques such as centrifugation, microfiltration, and depth filtration.
Centrifugation and microfiltration are two methods most commonly used for harvesting.
The cell harvesting market is predicted to touch USD 10.34 Billion by 2032.
The Americas is projected to command the largest share in the cell harvesting market.
Pharmaceutical companies will lead the cell harvesting market.
Mandatory licensing rules may limit market growth.
The cell harvesting market is projected to grow at an 12.9% CAGR between 2024-2032.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
